Why context of use, validation, and asset-level evaluation matter in pharmaceutical R&D On July 30, 2026, Vizuro took part in an expert roundtable hosted by Taiwan's Science & Technology Law Institute (STLI), Institute for Information Industry (III), on the use and governance of AI in the pharmaceutical industry. The discussion covered applications across R&D, manufacturing, quality, data management, and commercialization, and was later featured by Global Bio & Investment Mon